Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Frontiers in Immunology|September 22, 2025
Preliminarily evaluation the safety and immunogenicity of tetanus, reduced diphtheria and acellular pertussis (five components) combined vaccine, adsorbed (Tdcp) in participants aged 6 years and above: a blinded and randomised, and controlled phase I clinical trialXiaoyu Liu, Chen Wei, Haitao Huang, et al.
Human Vaccines & Immunotherapeutics|August 17, 2023
Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinical trialJianmin Chen, Feng Jiang, Chenyan Zhao, et al.
Neurobiology of Disease|May 18, 2025
Astrocytic AEG-1 drives neuroinflammation and enhances seizure susceptibilityYuzhou Chen, Yunbo Yu, Jinhao Kou, et al.
Frontiers in Immunology|September 27, 2024
Immune responses and transcription landscape of adults with the third dose of homologous and heterologous booster vaccines of COVID-19Hui Zheng, Cuidan Li, Xiuyu Zheng, et al.
Transplantation|April 29, 2015
Arsenic Trioxide Induces T Cell Apoptosis and Prolongs Islet Allograft Survival in MiceChang Gao, Jie Jiang, Pengfei Ma, et al.
Emerging Microbes & Infections|January 30, 2026
Safety and Immunogenicity of Diphtheria, Tetanus and Pertussis (Acellular, Three Components) Combined Vaccine, Adsorbed after three-dose priming in 2 Months Age Infants: A Randomized, Blinded, Controlled Phase III Clinical Trial in ChinaWei Zhang, Chen Wei, Peng Wan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 14, 2025
Circular RNA PTPN4 Contributes to Blood-Brain Barrier Disruption during Early EpileptogenesisJiurong Yang, Yang Hu, Feiyu Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 8, 2024
S100A9+CD14+ monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor functionXiaoxuan Tu, Longxian Chen, Yi Zheng, et al.
Frontiers in Immunology|June 11, 2026
Case Report: dynamic monocyte reprogramming during ALSS therapy in type B HBV-ACLF revealed by single-cell transcriptomicsJiale Xie, Jiahua Liu, Feiyu Wang, et al.
Pageof 10